Cutting edge: Discrete functions of mTOR signaling in invariant NKT cell development and NKT17 fate decision

Journal of Immunology

Volumn 193, Issue 9, 2014, Pages 4297-4301

  Wei, Jun ^a   Yang, Kai ^a   Chi, Hongbo ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INTERLEUKIN 17; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RAPTOR PROTEIN; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RETINOID RELATED ORPHAN RECEPTOR GAMMA T; RHEB PROTEIN; RICTOR PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; RICTOR PROTEIN, MOUSE; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL SURVIVAL; CONTROLLED STUDY; GENE DELETION; INVARIANT NATURAL KILLER T CELL; LYMPHOCYTOPOIESIS; MOUSE; NATURAL KILLER T CELL; NKT17 CELL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; THYMUS; UPREGULATION; ANIMAL; CYTOLOGY; DEFICIENCY; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINEAGE; IMMUNOPHENOTYPING; MICE; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TOR SERINE-THREONINE KINASES;

EID: 84908120735     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402042     Document Type: Article

References (21)

1. Salio, M., J. D. Silk, E. Y. Jones, and V. Cerundolo. 2014. Biology of CD1- and MR1-restricted T cells. Annu. Rev. Immunol. 32: 323-366.
2. Brennan, P. J., M. Brigl, and M. B. Brenner. 2013. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat. Rev. Immunol. 13: 101-117.
3. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
4. Kovalovsky, D., O. U. Uche, S. Eladad, R. M. Hobbs, W. Yi, E. Alonzo, K. Chua, M. Eidson, H. J. Kim, J. S. Im, et al. 2008. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9: 1055-1064.
5. Savage, A. K., M. G. Constantinides, J. Han, D. Picard, E. Martin, B. Li, O. Lantz, and A. Bendelac. 2008. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29: 391-403.
6. Lee, Y. J., K. L. Holzapfel, J. Zhu, S. C. Jameson, and K. A. Hogquist. 2013. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 14: 1146-1154.
7. Constantinides, M. G., and A. Bendelac. 2013. Transcriptional regulation of the NKT cell lineage. Curr. Opin. Immunol. 25: 161-167.
8. Chi, H. 2012. Regulation and function of mTOR signalling in T cell fate decisions. Nat. Rev. Immunol. 12: 325-338.
9. Powell, J. D., K. N. Pollizzi, E. B. Heikamp, and M. R. Horton. 2012. Regulation of immune responses by mTOR. Annu. Rev. Immunol. 30: 39-68.
10. Lee, K., P. Gudapati, S. Dragovic, C. Spencer, S. Joyce, N. Killeen, M. A. Magnuson, and M. Boothby. 2010. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 32: 743-753.
11. Delgoffe, G. M., K. N. Pollizzi, A. T. Waickman, E. Heikamp, D. J. Meyers, M. R. Horton, B. Xiao, P. F. Worley, and J. D. Powell. 2011. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 12: 295-303.
12. Kurebayashi, Y., S. Nagai, A. Ikejiri, M. Ohtani, K. Ichiyama, Y. Baba, T. Yamada, S. Egami, T. Hoshii, A. Hirao, et al. 2012. PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORγ. Cell Reports 1: 360-373.
13. Yang, K., S. Shrestha, H. Zeng, P. W. Karmaus, G. Neale, P. Vogel, D. A. Guertin, R. F. Lamb, and H. Chi. 2013. T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming. Immunity 39: 1043-1056.
14. Zeng, H., K. Yang, C. Cloer, G. Neale, P. Vogel, and H. Chi. 2013. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 499: 485-490.
15. Lee, K., K. T. Nam, S. H. Cho, P. Gudapati, Y. Hwang, D. S. Park, R. Potter, J. Chen, E. Volanakis, and M. Boothby. 2012. Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia. J. Exp. Med. 209: 713-728.
16. Shin, J., S. Wang, W. Deng, J. Wu, J. Gao, and X. P. Zhong. 2014. Mechanistic target of rapamycin complex 1 is critical for invariant natural killer T-cell development and effector function. Proc. Natl. Acad. Sci. USA 111: E776-E783.
17. Zhang, L., B. O. Tschumi, S. Corgnac, M. A. Ruegg, M. N. Hall, J. P. Mach, P. Romero, and A. Donda. 2014. Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function. J Immunol. 193: 1759-1765.
18. Wu, J., J. Yang, K. Yang, H. Wang, B. Gorentla, J. Shin, Y. Qiu, L. G. Que, W. M. Foster, Z. Xia, et al. 2014. iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions. J. Clin. Invest. 124: 1685-1698.
19. Yang, K., G. Neale, D. R. Green, W. He, and H. Chi. 2011. The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nat. Immunol. 12: 888-897.
20. Finlay, D. K., A. P. Kelly, R. Clarke, L. V. Sinclair, M. Deak, D. R. Alessi, and D. A. Cantrell. 2010. Temporal differences in the dependency on phosphoinositide-dependent kinase 1 distinguish the development of invariant Valpha14 NKT cells and conventional T cells. J. Immunol. 185: 5973-5982.
21. Kishimoto, H., T. Ohteki, N. Yajima, K. Kawahara, M. Natsui, S. Kawarasaki, K. Hamada, Y. Horie, Y. Kubo, S. Arase, et al. 2007. The Pten/PI3K pathway governs the homeostasis of Valpha14iNKT cells. Blood 109: 3316-3324.